Pdb60 - Cost-Consequence Analysis for Recombinant Human Growth Hormone Treatment Administered via Different Devices in Children With Growth Hormone Deficiency in Italy
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.765
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV